Abstract
Adenosine modulates several physiological functions in the CNS and in peripheral tissues via membrane receptors which have been classified into four adenosine subtypes. A1 activation produces neuronal depression: this inhibition allows A1 agonists to produce ischemic tolerance and protection in neuronal tissue. In order to selectively reproduce these effects, several A1 selective ligands have been synthesised and evaluated to understand how they interact with the adenosine A1 receptor. The investigation methods include SAR studies using native and chemically modified A1 receptors, molecular cloning of native and mutant adenosin A1 receptors, molecular modeling and thermodynamic analysis of drug-receptor interaction. Despite the great quantity of information available on the adenosine A1 receptor, no A1 agonist has so far entered in clinical use against brain diseases in view of the side effects, moreover selective A1 agonists appear to be poorly adsorbed into the brain and can be quickly degraded in vivo or in the whole blood. In an attempt to overcome these problems studies have been undertaken dealing with the use of partial agonists to inhibit side-effects and the employment of prodrugs to increase stability and diffusion through lipid barriers of A1 ligands. Other attempts involve either the use of A1 receptor enhancers as modulators able to locally enhance the action of endogenously produced adenosine, or the encapsulation of A1 agonists in drug delivery systems targeted to the brain. In this review, these approaches will be described together with the effects of adenosine A1 receptor ligands and their binding mechanisms on the central nervous system.
Current Medicinal Chemistry
Title: Adenosine A1 Receptor: Analysis of the Potential Therapeutic Effects Obtained by its Activation in the Central Nervous System
Volume: 9 Issue: 21
Author(s): Alessandro Dalpiaz and Stefano Manfredini
Affiliation:
Abstract: Adenosine modulates several physiological functions in the CNS and in peripheral tissues via membrane receptors which have been classified into four adenosine subtypes. A1 activation produces neuronal depression: this inhibition allows A1 agonists to produce ischemic tolerance and protection in neuronal tissue. In order to selectively reproduce these effects, several A1 selective ligands have been synthesised and evaluated to understand how they interact with the adenosine A1 receptor. The investigation methods include SAR studies using native and chemically modified A1 receptors, molecular cloning of native and mutant adenosin A1 receptors, molecular modeling and thermodynamic analysis of drug-receptor interaction. Despite the great quantity of information available on the adenosine A1 receptor, no A1 agonist has so far entered in clinical use against brain diseases in view of the side effects, moreover selective A1 agonists appear to be poorly adsorbed into the brain and can be quickly degraded in vivo or in the whole blood. In an attempt to overcome these problems studies have been undertaken dealing with the use of partial agonists to inhibit side-effects and the employment of prodrugs to increase stability and diffusion through lipid barriers of A1 ligands. Other attempts involve either the use of A1 receptor enhancers as modulators able to locally enhance the action of endogenously produced adenosine, or the encapsulation of A1 agonists in drug delivery systems targeted to the brain. In this review, these approaches will be described together with the effects of adenosine A1 receptor ligands and their binding mechanisms on the central nervous system.
Export Options
About this article
Cite this article as:
Dalpiaz Alessandro and Manfredini Stefano, Adenosine A1 Receptor: Analysis of the Potential Therapeutic Effects Obtained by its Activation in the Central Nervous System, Current Medicinal Chemistry 2002; 9 (21) . https://dx.doi.org/10.2174/0929867023368917
DOI https://dx.doi.org/10.2174/0929867023368917 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic Insights into Sepsis: What have we Learned and How will it Help?
Current Pharmaceutical Design Endoplasmic Reticulum and Mitochondria: Independent Roles and Crosstalk in Fatty Liver Diseases and Hepatic Inflammation
Current Pharmaceutical Design Salidroside - Can it be a Multifunctional Drug?
Current Drug Metabolism Novel Methods of Insulin Replacement: The Artificial Pancreas and Encapsulated Islets
Reviews on Recent Clinical Trials Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Mini-Reviews in Medicinal Chemistry Blockade of Neoangiogenesis, a New and Promising Technique to Control the Growth of Malignant Tumors and their Metastases
Current Vascular Pharmacology Catatonia: A Narrative Review
Central Nervous System Agents in Medicinal Chemistry Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis
Current Medicinal Chemistry A 1536-Well Fluorescence Polarization Assay to Screen for Modulators of the MUSASHI Family of RNA-Binding Proteins
Combinatorial Chemistry & High Throughput Screening The Role of Amino Acids in the Modulation of Cardiac Metabolism During Ischemia and Heart Failure
Current Pharmaceutical Design Recent Applications of DNA Sequencing Technologies in Food, Nutrition and Agriculture
Recent Patents on Food, Nutrition & Agriculture Genetic and Non-genetic Determinants of Cardiovascular Disease in South Asians
Current Diabetes Reviews Mitochondrial Dysfunction in the Pathophysiology of Bipolar Disorder: Effects of Pharmacotherapy
Mini-Reviews in Medicinal Chemistry Optimized Methods for In Vitro and In Vivo Anti-Inflammatory Assays and Its Applications in Herbal and Synthetic Drug Analysis
Mini-Reviews in Medicinal Chemistry Viewpoints on Medical Image Processing: From Science to Application
Current Medical Imaging Therapeutic Window, a Critical Developmental Stage for Stem Cell Therapies
Current Stem Cell Research & Therapy Parathyroid Hypertension: A Rare, but Curable form of Secondary Hypertension
Current Hypertension Reviews Improving Cancer Care for Children in the Developing World: Challenges and Strategies
Current Pediatric Reviews Myelin Sheaths and Autoimmune Response Induced by Myelin Proteins and Alphaviruses. I. Physicochemical Background
Current Medicinal Chemistry The Role of Insulin-Like Growth Factor I Components in the Regulation of Vitamin D
Current Pharmaceutical Biotechnology